XML 51 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Net Loss Per Share - Summary of Dilutive Securities Not Included in the Diluted Net Loss Per Common Share (Detail) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 4,922,019 24,191,516
Exercise of Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 4,922,019 3,481,178
Series A Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 0 477,297
Series A1 Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 0 7,537,879
Series B Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 0 11,862,043
Common stock warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 0 385,693
Preferred stock warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Conversion of stock, shares converted 0 447,426